NCT07367464

Brief Summary

This study aims to evaluate the effect of Allogenic bone graft mixed with Xenograft in ratio 1:1, on the radiographic and histomorphometric assessment versus Autologous bone graft mixed with Xenograft in ratio 1:1 in maxillary deficient ridges، In guided bone regeneration of deficient edentulous maxillary ridges, will the application of Xenograft mixed with Allograft (1:1) be as effective as Xenograft mixed with Autogenous graft (1:1) in terms of dimensional ridge changes and Quality of newly formed bone? Evaluation of the patient's general condition of the oral cavity, to make sure it complies with the criteria required to be enrolled in the study in terms of oral hygiene and pathological conditions. A full thickness flap will be elevated with two releasing incisions, decortication of the buccal aspect of the ridge, placing of grafting material which will be covered by collagen pericardium membranes, tacks placement at the labial side to fix the membrane in place, horizontal mattress sutures as well as single interrupted and continuous with resorbable sutures for closure. Intervention group: will be filled with mixture of Xenogenic graft and the Allogenic bone graft chips. Control group: will be filled with mixture of Xenogenic graft and Autogenous bone particulate harvested either the ramus. For both groups, All the subjects will be taking CBCT at pre surgical and 6 months post surgical. outcomes : Bucco-Palatal horizontal bone gain, Alveolar ridge height, Percentage of new vital bone formation and Percentage of residual bone graft 6 months post-surgical.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jun 2024Jun 2026

Study Start

First participant enrolled

June 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 14, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

1.5 years

First QC Date

January 14, 2026

Last Update Submit

April 9, 2026

Conditions

Keywords

Guided Bone RegenerationDFDBAAutogenous Bone GraftXenograftXenograft Mixed With Autogenous Bone GraftXenograft Mixed With Allogenic Bone GraftDeficient Maxillary Alveolar Ridges

Outcome Measures

Primary Outcomes (1)

  • Bucco-Palatal horizontal bone gain

    Bone width will be measured from the reformatted cross-sectional image of the CBCT 2 mm below the tip of the crest at every single deficient site taking a specific anatomical landmark in the opposing teeth as a reference point for the measurements taking into consideration that the patients are biting in maximum intercuspation. The average of these measurements will be calculated to be a representative value of the preoperative width for each case from the preoperative CBCT. Immediate and 6 months postoperative CBCT will be done while the patients are also biting in maximum intercuspation and the same measurements will be taken from the same reference areas previously selected from the preoperative scan.

    6 months postoperatively

Secondary Outcomes (3)

  • Alveolar ridge height:

    6 months postoperatively

  • Percentage of new vital bone formation

    6 months postoperatively

  • Percentage of residual bone graft

    6 months postoperatively

Study Arms (2)

Allogenic bone graft mixed with Xenograft in ratio 1:1

EXPERIMENTAL

A full thickness flap will be elevated with two releasing incisions extending at least just distal to each tooth adjacent to the defect site.The flap will be reflected adequately to expose the defect. The cortical bone will be perforated with a small round bur to perform decortication of the buccal aspect of the ridge. recipient site will be debrided from any soft tissue or periosteum remnants.The grafts will be placed on the buccal aspect of the alveolar ridge, layer by layer, gently pressed to the recipient site then it will be covered by a collagen pericardium membranes. The membrane will be stretched tightly over the graft and titanium tacks will be placed at the labial side to fix the membrane in place. The incisions will be carefully closed with horizontal mattress sutures as well as single interrupted and continuous with resorbable sutures.

Biological: Allogenic bone graft mixed with Xenograft in ratio 1:1

Autologous bone graft mixed with Xenograft in ratio 1:1

ACTIVE COMPARATOR

A full thickness flap will be elevated with two releasing incisions extending at least just distal to each tooth adjacent to the defect site.The flap will be reflected adequately to expose the defect. The cortical bone will be perforated with a small round bur to perform decortication of the buccal aspect of the ridge. recipient site will be debrided from any soft tissue or periosteum remnants.The grafts will be placed on the buccal aspect of the alveolar ridge, layer by layer, gently pressed to the recipient site then it will be covered by a collagen pericardium membranes. The membrane will be stretched tightly over the graft and titanium tacks will be placed at the labial side to fix the membrane in place. The incisions will be carefully closed with horizontal mattress sutures as well as single interrupted and continuous with resorbable sutures.

Biological: Autologous bone graft mixed with Xenograft in ratio 1:1

Interventions

Autogenous bone particulate will be harvested from the mandibular ramus. Mandibular ramus as a donor site: A submarginal incision will be placed within the keratinized mucosa opposite to the lower first molar and extending 1 cm along the ramus of the mandible.

Autologous bone graft mixed with Xenograft in ratio 1:1

Xenogenic graft is then to be mixed in equal 1:1 volume of particles size 0.25-1 mm with the Allogenic bone graft chips to create 1:1 composite graft.

Allogenic bone graft mixed with Xenograft in ratio 1:1

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 20-50 years.
  • Totally or partially edentulous maxillary ridges.
  • Patients with insufficient bone for an implant placement.
  • Residual alveolar width ranging from 2 to 4 mm.
  • Minimum of 10 mm vertical dimension to nasal floor or sinus floor.
  • Patients with healthy systemic condition (Medically free).
  • Adequate inter-arch space for placement of the implant prosthetic part.

You may not qualify if:

  • Pathological lesions in the defect site.
  • Systemic diseases that would interfere with bone metabolism. Uncontrolled diabetic patients.
  • Ongoing treatment or a history of recent chemotherapy or radiotherapy.
  • Patient with medical condition that contraindicates surgical procedures.
  • Patients on medication that may interfere with healing (Corticosteroids, Bisphosphonate, Chemo/radio therapy).
  • Patients with vertical bone deficiency.
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or para-functional habits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry Cairo University

Cairo, Egypt

RECRUITING

MeSH Terms

Interventions

Transplantation, Heterologous

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, Operative

Study Officials

  • Mohamed A. Abousetta, Bachelor

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Mohamed M. Shaker, Professor

    Cairo University

    STUDY CHAIR
  • Weam A. El-Battawy, Ass. Prof.

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinding of the participants and the operator is not applicable, however outcome assessors and bio-statistician will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master Degree student, Implantology department, Faculty of Dentistry, Cairo University

Study Record Dates

First Submitted

January 14, 2026

First Posted

January 26, 2026

Study Start

June 1, 2024

Primary Completion

December 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

April 14, 2026

Record last verified: 2026-04

Locations